Kite Pharma, Inc. Proceeds from Convertible Debt
Kite Pharma, Inc. reported Proceeds from Convertible Debt of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2017-02-28
- Kite Pharma, Inc. proceeds from convertible debt for the quarter ending 2014-12-31 was $0.00.
- Kite Pharma, Inc. proceeds from convertible debt for the quarter ending 2014-09-30 was $0.00.
- Kite Pharma, Inc. proceeds from convertible debt for fiscal 2016 was $0.00.
- Kite Pharma, Inc. proceeds from convertible debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Kite Pharma, Inc. proceeds from convertible debt for fiscal 2014 was $50.00M.
- Kite Pharma, Inc. proceeds from convertible debt for fiscal 2012 was $250.00K.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $50.00M 10-K · filed 2017-02-28 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $50.00M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $50.00M 10-Q · filed 2015-08-10 | |||
| 2012-12-31 | $250.00K 10-K · filed 2015-03-26 |